Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Leukemia Research|June 25, 2023
mRNA-1273 SARS-CoV-2 vaccine in recently transplanted allogeneic hematopoietic cell transplant recipients: Dynamics of cellular and humoral immune responses and booster effectNil Albiol, Elionor Lynton-Pons, Olga Aso, et al.
Cells|November 27, 2024
Association of Genomic Alterations with the Presence of Serum Monoclonal Proteins in Chronic Lymphocytic LeukemiaJuan A Piñeyroa, Irene López-Oreja, Ferran Nadeu, et al.
Open Forum Infectious Diseases|June 12, 2026
Infections in Patients With Cytokine Release Syndrome/Immune Effector Cell-Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T-Cell TherapyAntonio Gallardo-Pizarro, Miquel Ariño, Carlos Lopera, et al.
Annals of Hematology|May 11, 2026
Academic BCMA CAR-T (ARI0002h) achieves MRD-negative remission with sBCMA biomarker response in relapsed POEMS syndrome after double ASCTVíctor Torrecillas-Mayayo, Aina Oliver-Caldes, Nuria Martínez-Cibrian, et al.
British Journal of Haematology|June 4, 2026
Cesni-cel (ARI0002h) in ultra-high-risk multiple myeloma with plasma cell leukaemia or central nervous system involvementCarlos Jimenez-Mira, Natalia Tovar, Núria Martínez-Cibrián, et al.
International Journal of Molecular Sciences|October 16, 2025
Combining CAR T-Cell Therapy and Nivolumab to Overcome Immune Resistance in THRLBCL: A Case ReportDaniel Munarriz, Oriana López-Godino, Nuria Martinez-Cibrian, et al.
Hemasphere|September 15, 2025
Efficacy and safety of the academic anti-CD19 chimeric antigen receptor T-cell product varnimcabtagene autoleucel for the treatment of relapsed/refractory follicular lymphomaNúria Martínez-Cibrián, Valentín Ortiz-Maldonado, Marta Español-Rego, et al.
Hemasphere|June 8, 2026
Varnimcabtagene autoleucel (ARI-0001) in relapsed or refractory mantle cell lymphomaNil Albiol, Nuria Martínez-Cibrián, Amanda Isabel Pérez, et al.
The Lancet. Haematology|February 6, 2026
Varnimcabtagene autoleucel for adults with relapsed or refractory B-cell precursor acute lymphoblastic leukaemia in Spain (CART19-BE-02): a multicentre, single-arm, phase 2 trialValentín Ortiz-Maldonado, Núria Martínez-Cibrian, Leticia Alserawan, et al.
Pageof 2